Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the

Dow Jones Industrial Average

(

^DJI

) trading down 24 points (-0.1%) at 16,982 as of Wednesday, Oct. 29, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,291 issues advancing vs. 1,724 declining with 155 unchanged.

The Health Services industry currently sits down 0.5% versus the S&P 500, which is down 0.2%. Top gainers within the industry include

Aetna

(

AET

), up 2.9%,

WellPoint

(

WLP

), up 2.0% and

UnitedHealth Group

(

UNH

), up 0.6%. A company within the industry that fell today was

Intuitive Surgical

(

ISRG

), up 1.7%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Cigna

(

CI

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Cigna is up $1.22 (1.3%) to $93.80 on heavy volume. Thus far, 1.1 million shares of Cigna exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $92.69-$94.09 after having opened the day at $92.90 as compared to the previous trading day's close of $92.58.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $24.4 billion and is part of the health care sector. Shares are up 5.8% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts who rate Cigna a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Cigna

as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full

Cigna Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Recommends

2. As of noon trading,

Covidien

(

COV

) is up $1.50 (1.7%) to $91.50 on light volume. Thus far, 1.4 million shares of Covidien exchanged hands as compared to its average daily volume of 5.4 million shares. The stock has ranged in price between $90.00-$91.80 after having opened the day at $90.00 as compared to the previous trading day's close of $90.00.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $40.4 billion and is part of the health care sector. Shares are up 32.2% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts who rate Covidien a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates

Covidien

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Covidien Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading,

Medtronic

(

MDT

) is up $0.49 (0.7%) to $67.00 on average volume. Thus far, 3.7 million shares of Medtronic exchanged hands as compared to its average daily volume of 9.2 million shares. The stock has ranged in price between $66.23-$67.36 after having opened the day at $66.50 as compared to the previous trading day's close of $66.51.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It operates through three segments: Cardiac and Vascular Group, Restorative Therapies Group, and Diabetes Group. Medtronic has a market cap of $64.9 billion and is part of the health care sector. Shares are up 15.9% year-to-date as of the close of trading on Tuesday. Currently there are 13 analysts who rate Medtronic a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates

Medtronic

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Medtronic Ratings Report

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

null